U.S. Electric Utilities Stock News

If you are trying to figure out whether Precigen's current share price reflects its underlying value, you are not alone. This article is built to walk you through that question step by step. The stock last closed at US$3.28, with returns of 88.5% over 1 year and 203.7% over 3 years, but also a 29.6% decline over 30 days and a 23.4% decline year to date. These moves can change how investors think about both potential and risk. Recent company updates and sector news have kept Precigen on many...

If you are wondering whether Enovix at around US$4.92 is starting to look interesting or still too risky for your portfolio, this article will help you size up what you are really paying for. The share price has been under pressure, with returns of a 2.6% decline over 7 days, 21.7% decline over 30 days, 37.6% decline year to date, 31.8% decline over 1 year, 54.7% decline over 3 years and 67.4% decline over 5 years. Recent coverage has focused on Enovix's position in advanced battery...

Reynolds Consumer Products is facing ongoing weak demand, with unit sales declining for two consecutive years. The company may need to invest in new product improvements to address softer demand across its core categories. These trends raise questions about how Reynolds Consumer Products, traded as NasdaqGS:REYN, will respond to protect its position in household goods. Reynolds Consumer Products, the company behind many everyday kitchen and household items, is under pressure as unit sales...

Gaming and Leisure Properties, NasdaqGS:GLPI, has arranged a new $679 million term loan under an amended credit agreement. The company has fully repaid and terminated a prior term loan facility as part of this refinancing move. This refinancing aligns with management's efforts to manage the capital structure and extend debt maturities. For investors watching Gaming and Leisure Properties, the refinancing comes with the stock trading at $48.36 and a multi year return of 57.2% over the past 5...

If you are wondering whether Wealthfront's current share price matches its underlying worth, you are not alone. This article will focus squarely on how the stock lines up against a range of valuation checks. Wealthfront shares last closed at US$7.88, with a return of a 10.4% decline over the past 7 days and a 3.9% decline over the past 30 days, while the year-to-date return stands at a 40.4% decline. Recent coverage around Wealthfront has focused on its position within diversified financials...

Geopolitical tensions in the Middle East have disrupted traffic through the Strait of Hormuz, affecting global fertilizer flows and grain shipping routes. The supply shock has pushed fertilizer and grain prices higher, lifting margin potential for Andersons' Agribusiness and Renewables units. These developments are emerging as a fresh driver for NasdaqGS:ANDE that has not featured in earlier discussions of the stock. For investors tracking NasdaqGS:ANDE, this new supply disruption adds a...

If you are wondering whether CG Oncology's current share price still offers value after a strong run, you are not alone. This article is designed to help you frame that question clearly. CG Oncology last closed at US$62.97, with reported returns of 4.3% over the past week, 18.6% over the past month, 50.7% year to date and 142.7% over the past year. These figures naturally raise questions about how expectations and risk are now being priced in. Recent interest in CG Oncology has been driven...

Investors may be wondering if Bristow Group at around US$42.99 is offering good value right now, or if the recent run has already priced in the key positives. The stock has pulled back over the last week and month, with 7 day and 30 day returns of a 3.5% decline and a 4.0% decline, but it still sits on gains of 15.1% year to date, 39.0% over the past year, 95.9% over three years, and 67.0% over five years. Recent attention on Bristow Group has been driven by its role within the energy and...

Imperial Petroleum Inc. recently reported fourth-quarter 2025 results, with sales of US$51.14 million and net income of US$14.96 million, and also declared a US$0.546875 preferred dividend on its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock for payment on March 30, 2026. While quarterly sales and earnings increased compared with the prior year’s quarter, full-year 2025 net income and earnings per share from continuing operations remained broadly in line with 2024 levels,...

Trupanion (NasdaqGM:TRUP) announced a new partnership with the Human Animal Bond Research Institute (HABRI). The collaboration focuses on research and advocacy that supports the human and animal connection, including pet owners, veterans, service animals, and special populations. The initiative aims to use data driven insights to inform programs and policies that affect pet and human welfare. For you as an investor, this adds another layer to Trupanion's core pet insurance business. The...

Matson announced the upcoming retirement of Executive Vice President and Chief Commercial Officer John Lauer and named Chris Scott as his successor. The company outlined additional leadership promotions connected to this transition. Matson also launched a new cargo security initiative with BNSF Railway and War-Lok, adding multiple layers of protection for international intermodal cargo. Matson (NYSE:MATX) is pairing major leadership changes with an operational shift in how it protects...

Gambling.com Group (GAMB) closed FY 2025 with Q4 revenue of US$46.2 million and a basic EPS loss of US$0.77, alongside a trailing twelve month basic EPS loss of US$0.93 on revenue of US$165.4 million. The company has seen quarterly revenue move from US$35.3 million and basic EPS of US$0.23 in Q4 2024 to US$46.2 million with a basic EPS loss of US$0.77 in Q4 2025, while trailing twelve month revenue shifted from US$127.2 million with basic EPS of US$0.85 in Q4 2024 to US$165.4 million with a...

Century Therapeutics (IPSC) just posted FY 2025 results that put revenue at US$109.2 million with basic EPS of US$0.51 for the latest half, against a trailing twelve month profile that still shows a loss, with EPS of US$0.11 and net income of US$9.6 million in the red on US$109.2 million of revenue. Over the past year, the company has reported revenue of US$1.6 million and EPS of US$0.82 in early 2024, then US$4.96 million with EPS of US$0.79 in the second half of 2024, and then the latest...

CareCloud (CCLD) has capped FY 2025 with fourth quarter revenue of US$34.4 million and basic EPS of US$0.04, alongside trailing 12 month revenue of US$120.5 million and basic EPS of US$0.10, marking a clean move away from the losses seen earlier in the period. The company has seen quarterly revenue step up from US$27.4 million in Q2 2025 to US$34.4 million in Q4 2025, while quarterly basic EPS has shifted from a loss of US$0.04 in Q1 2025 to positive readings in each subsequent quarter,...

Trinity Capital (NasdaqGS:TRIN) has recently committed growth capital to three MedTech companies: Monteris Medical, Emboline, and Neuros Medical. The financing supports commercialization of Monteris Medical's neurosurgical system, Emboline's heart procedure protection platform, and Neuros Medical's non opioid pain treatment device. These back to back commitments expand Trinity Capital's exposure to advanced medical technologies within its venture lending portfolio. Trinity Capital focuses...

Voyager Therapeutics, Inc. recently reported fourth-quarter 2025 results showing a net loss of US$27.43 million, improving from US$34.49 million a year earlier, while its full-year 2025 net loss widened to US$119.72 million from US$65.00 million in 2024. Although Voyager reduced its quarterly loss per share, the much larger full-year loss highlights the cost intensity of advancing its neurological disease pipeline. We’ll now examine how Voyager’s improved quarterly loss but much larger...

Zurn Elkay Water Solutions (NYSE:ZWS) reported record annual performance with double digit core sales growth. The company highlighted improved operating margins over the year. Management announced a substantial increase in its dividend. The company also disclosed a significant share repurchase program. Zurn Elkay Water Solutions focuses on water management products and systems, an area that sits at the intersection of infrastructure, building construction, and resource efficiency. With...

Montauk Renewables (MNTK) closed out FY 2025 with Q4 revenue of US$43.4 million and basic EPS of US$0.02 on net income of US$2.5 million, setting the tone for a year where reported earnings and margins were under close watch. The company has seen quarterly revenue move from US$27.7 million and basic EPS of US$0.06 in Q4 2024 to a mix of losses and profits through 2025, including Q2 revenue of US$45.1 million with a loss of US$5.5 million and basic EPS of US$0.04, before landing on US$45.3...

Sleep Number (SNBR) has capped FY 2025 with fourth quarter revenue of US$347.4 million and a basic EPS loss of US$2.55, as net income excluding extra items came in at a loss of US$58.5 million. The company has seen quarterly revenue move from US$393.3 million in Q1 2025 to US$327.9 million in Q2, US$342.9 million in Q3 and US$347.4 million in Q4, alongside a widening basic EPS loss over the same stretch. For investors, that mix of steady sales levels and deeper losses keeps the focus firmly...

Q32 Bio (QTTB) has just posted its FY 2025 numbers, reporting fourth quarter revenue of US$53.7 million and basic EPS of US$4.60, alongside trailing 12 month basic EPS of US$2.42 and net income of US$29.8 million. The company’s quarterly revenue has moved from US$0 and a basic EPS loss of US$1.16 in Q4 2024 to US$53.7 million and US$4.60 in Q4 2025. Interim 2025 quarters showed no revenue and basic EPS losses between US$0.60 and US$0.90, so investors will likely focus on how durable these...

LifeMD (LFMD) is back in focus after its latest earnings, where the telehealth provider reported full year 2025 net income of US$14.35 million and issued fresh 2026 revenue guidance. See our latest analysis for LifeMD. LifeMD’s latest earnings and 2026 guidance have arrived after a sharp recent move, with a 7 day share price return of 31.17% and a 30 day share price return of 29.02% despite a 1 year total shareholder return decline of 30.48%. Short term momentum is building, while the longer...

Bumble (BMBL) has returned to investor attention after Q4 2025 earnings topped expectations, first quarter 2026 revenue guidance of US$209 million to US$213 million, and the announcement of new AI driven product and platform plans. See our latest analysis for Bumble. The Q4 surprise and AI rollout have triggered a sharp shift in sentiment, with a 34.2% 1-day share price return and 21.7% 7-day share price return contrasting with a 1-year total shareholder return of negative 20%. This suggests...

Resolute Holdings Management (RHLD) has put out a mixed set of FY 2025 numbers, with Q3 revenue at US$120.9 million and a small net loss of US$0.2 million, translating to basic EPS of US$0.03 loss per share. Over recent quarters the company has seen revenue move from US$103.9 million in Q1 FY 2025 to US$119.6 million in Q2 and US$120.9 million in Q3. EPS shifted from a US$0.39 loss to a US$0.07 loss and then to a US$0.03 loss, setting the backdrop for investors who are watching how much of...

Kansas City Life Insurance (KCLI) has wrapped up FY 2025 with fourth quarter revenue of US$120.4 million, basic EPS of US$0.23 and net income of US$2.3 million, alongside trailing 12 month revenue of US$485.5 million and a net loss of US$20.8 million, which translates to basic EPS of a US$2.14 loss. Over recent quarters the company has seen revenue move between US$118.98 million and US$125.15 million, while quarterly EPS has ranged from a US$2.90 loss to a US$0.33 profit. This sets up a story...